Biomaterial Database

OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients. 1994

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

Department of Pediatrics and Surgery, University and Children's Hospital of Western Ontario, London, Canada.

UI	MeSH Term	Description	Entries
D007165	Immunosuppression Therapy	Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.	Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007223	Infant	A child between 1 and 23 months of age.	Infants
D008297	Male		Males
D008775	Methylprednisolone	A PREDNISOLONE derivative with similar anti-inflammatory action.	6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D005260	Female		Females
D006084	Graft Rejection	An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.	Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293	Adolescent	A person 13 to 18 years of age.	Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

Induction therapy with OKT3 in pediatric liver-transplant recipients.

December 1994, Transplantation science,

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

OKT3 and viral disease in pediatric liver transplant recipients.

August 1991, Clinical transplantation,

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

Towards minimizing immunosuppression in pediatric liver transplant recipients.

August 2009, Pediatric transplantation,

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

Immunosuppression in pediatric liver transplant recipients: Unique aspects.

February 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

OKT3 prophylaxis in liver transplant patients.

June 1990, Transplantation,

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients.

January 1992, Journal of pediatric gastroenterology and nutrition,

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression.

January 2003, Transplantation,

J F Sommerauer, and P Atkison, and J Howard, and D Grant, and W Wall

Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.

October 1990, Transplantation proceedings,